Discover how the FDA’s Early Feasibility Studies (EFS) Program is revolutionizing medical device approvals in the U.S., and how MDIC is enhancing this process, in this insightful interview with Cyrano Therapeutics CEO Rick Geoffrion.
Discover how the FDA’s Early Feasibility Studies (EFS) Program is revolutionizing medical device approvals in the U.S., and how MDIC is enhancing this process, in this insightful interview with Cyrano Therapeutics CEO Rick Geoffrion.